Real world virologic outcomes in patients with elevated body mass index receiving long acting cabotegravir/rilpivirine.
Maguire C, Rueve K, Farmer E, Huesgen E, Karaj A, Binkley A, Mounzer K, Brizzi M, Chary P, Sung P, Graziani A, Hiserodt E, Baron J, Koenig H, Short WR.
Maguire C, et al. Among authors: koenig h.
Clin Infect Dis. 2024 Nov 27:ciae579. doi: 10.1093/cid/ciae579. Online ahead of print.
Clin Infect Dis. 2024.
PMID: 39602809